Microbial consortium and uses thereof
AssigneeThe Regents of the University of California
InventorsSusan Lynch, Nikole Kimes, Din Lin, Ricardo Valladares, Kei Fujimura
Life of this patent
Estimating the term…
Abstract
Provided herein are, inter alia, microbial compositions and methods of using the same. The microbial compositions provided include, inter alia, therapeutically effective amounts of Lactobacillus johnsonii, Faecalibacterium prausnitzii, Akkermansia muciniphila, Myxococcus xanthus and Pediococcus pentosaceus and are particularly useful for methods of treating and preventing inflammatory diseases.
Claims21
1-25. (canceled)
A pharmaceutical composition comprising a purified bacterial population comprising Pediococcus sp., Myxococcus sp., and Clostridium sp.
A pharmaceutical composition comprising a purified bacterial population comprising Pediococcus sp., Cystobacter sp., and Clostridium sp.
A method for treating or preventing an allergic inflammation in a subject in need thereof, comprising administering to the subject a pharmaceutical composition comprising a purified bacterial population, wherein the purified bacterial population comprises Myxococcus sp., Cystobacter sp., and Clostridium sp.
Dependencies are inferred from the claim text.